Anthropic Acquires Biotech Startup Coefficient Bio for $400 Million

TLDR

Anthropic has completed the acquisition of Coefficient Bio, a stealth biotech AI startup, in a $400 million all-stock transaction. The deal represents a significant expansion of Anthropic's business beyond its core AI development into the biotechnology sector, where large language models can accelerate research processes from protein structure prediction to drug candidate identification.

The all-stock nature of the deal means Coefficient Bio shareholders received Anthropic equity rather than cash, a structure common among well-capitalized private companies seeking to preserve liquidity. This acquisition follows a broader trend of major AI companies diversifying into adjacent sectors where machine learning can provide competitive advantages.

Key Takeaways

• Anthropic has purchased stealth biotech AI startup Coefficient Bio in a $400M all-stock deal, expanding its reach into biological research and drug development